NAVCO Pharmaceuticals Inc. Share Price

Equities

NAV

CA63942R1091

Personal Products

Market Closed - Toronto S.E. 14:30:00 13/05/2024 BST 5-day change 1st Jan Change
0.03 CAD 0.00% Intraday chart for NAVCO Pharmaceuticals Inc. 0.00% +20.00%

Financials

Sales 2022 58.73K 43.07K 3.42M Sales 2023 - Capitalization 1.21M 888K 70.4M
Net income 2022 - 0 0 Net income 2023 -2M -1.47M -116M EV / Sales 2022 * -
Net Debt 2022 896K 657K 52.14M Net Debt 2023 370K 271K 21.51M EV / Sales 2023 -
P/E ratio 2022 *
-
P/E ratio 2023
-0.42 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
Current month-14.29%
1 month+20.00%
6 months-25.00%
Current year+20.00%
More quotes
1 week
0.03
Extreme 0.03
0.06
1 month
0.02
Extreme 0.02
0.06
Current year
0.02
Extreme 0.02
0.08
1 year
0.02
Extreme 0.02
0.10
3 years
0.00
Extreme 0
0.45
5 years
0.00
Extreme 0
0.45
10 years
0.00
Extreme 0
0.45
More quotes
Date Price Change Volume
13/05/24 0.03 0.00% 2,059

Delayed Quote Toronto S.E., May 13, 2024 at 02:30 pm

More quotes
Navco Pharmaceuticals Inc. is a Canada-based company. The Company is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. It manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The Company's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. It offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. It also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.
More about the company